 |
MISSION & STRATEGY
STRATEGY
CLINICAL & REGULATORY STRATEGY
COMMERCIALIZATION
HISTORY
TEAM
|
|
ADVENTRX Pharmaceuticals is a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases. We seek to improve the performance and safety of existing treatments by addressing significant problems, such as drug metabolism and bioavailability, excessive toxicity and treatment resistance. We hold certain exclusive rights to new therapies for cancer and infectious diseases, including a lead compound, ANX-510 (CoFactor), which is designed to improve the performance and safety of 5-fluorouracil, a widely used chemotherapy. Coupled with these products is an experienced management team with significant product development, clinical, regulatory, finance, and business management expertise.
|
|
|
